The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.
about
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenograftsPrognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.Role of hypoxia-inducible factor-1α and survivin in oxygen-induced retinopathy in mice.Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated AnalysisEffects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma.Diagnostic and Prognostic Significance of Ki-67 Immunohistochemical Expression in Surface Epithelial Ovarian Carcinoma.Deficiency of CCAAT/enhancer binding protein family DNA binding prevents malignant conversion of adenoma to carcinoma in NNK-induced lung carcinogenesis in the mouseP53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas.Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population.Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortiumSurvivin and gliomas: A literature reviewExpression of CDK6 in Oral Squamous Cell CarcinomasDetecting proliferation of adult hemocytes in Drosophila by BrdU incorporation.
P2860
Q30277635-3750AE60-5A81-4F3C-9B3C-2CA60965CFE2Q33687123-3CE9928D-1E19-4B89-B04F-F638099600E1Q34170606-96F5702B-06B3-422B-8CAE-592D15F4565AQ34255022-97E77AAC-AA5E-42A7-A664-A12DD8EFDF02Q34501989-0E91D27A-863F-4E63-8916-99BFF97C5DDFQ34717034-87E828CF-17AC-4769-99B2-4412A0D002CCQ35788622-FA012D2A-733C-4F98-BBFC-BACA48D682CFQ35919592-2AAC094A-9A69-4C5E-926C-116FB54B1793Q36202284-1FA2E800-0864-441A-9A4D-3BCD7D57C99FQ36338865-2A851752-6C95-4B60-B44E-5D6E32088364Q36544436-64AC939E-1028-471B-9FD3-A3C5F2ED6834Q36604195-DCE95440-CD25-4ED6-8E0D-C8F26DBB6218Q36836496-927CEEAC-1341-4C9E-9792-B47348EA4365Q37096479-20CD5F3D-24E4-4F32-9FB5-B92F6C040998Q37359509-53773607-BA02-4570-9BF0-BB90CCB946DDQ38944673-4577954A-9359-463F-84BE-C3A60AEFDB8CQ52716791-0C33FC90-8757-48C9-BCC5-A87BB9E2A43DQ55285365-7376E77A-E70A-4CCE-BC25-C63C6D5EE677
P2860
The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The proliferation markers Ki-6 ...... aggressive ovarian carcinomas.
@ast
The proliferation markers Ki-6 ...... aggressive ovarian carcinomas.
@en
type
label
The proliferation markers Ki-6 ...... aggressive ovarian carcinomas.
@ast
The proliferation markers Ki-6 ...... aggressive ovarian carcinomas.
@en
prefLabel
The proliferation markers Ki-6 ...... aggressive ovarian carcinomas.
@ast
The proliferation markers Ki-6 ...... aggressive ovarian carcinomas.
@en
P2093
P2860
P1476
The proliferation markers Ki-6 ...... aggressive ovarian carcinomas.
@en
P2093
Astrid K Stunes
Oyvind Salvesen
Solveig Tingulstad
Sverre H Torp
Unni Syversen
P2860
P304
P577
2011-06-11T00:00:00Z